Imaging and clinical data indicate considerable disease burden in ‘probable’ PLS: Patients with UMN symptoms for 2–4 years
Eoin Finegan,
We Fong Siah,
Stacey Li Hi Shing,
Rangariroyashe H. Chipika,
Kai Ming Chang,
Mary Clare McKenna,
Mark A. Doherty,
Jennifer C. Hengeveld,
Alice Vajda,
Colette Donaghy,
Siobhan Hutchinson,
Russel L. McLaughlin,
Orla Hardiman,
Peter Bede
Affiliations
Eoin Finegan
Computational Neuroimaging Group, Biomedical Sciences Institute, Trinity College Dublin, Ireland
We Fong Siah
Computational Neuroimaging Group, Biomedical Sciences Institute, Trinity College Dublin, Ireland
Stacey Li Hi Shing
Computational Neuroimaging Group, Biomedical Sciences Institute, Trinity College Dublin, Ireland
Rangariroyashe H. Chipika
Computational Neuroimaging Group, Biomedical Sciences Institute, Trinity College Dublin, Ireland
Kai Ming Chang
Computational Neuroimaging Group, Biomedical Sciences Institute, Trinity College Dublin, Ireland; Electronics and Computer Science, University of Southampton, Southampton, United Kingdom
Mary Clare McKenna
Computational Neuroimaging Group, Biomedical Sciences Institute, Trinity College Dublin, Ireland
Mark A. Doherty
Complex Trait Genomics Laboratory, Smurfit Institute of Genetics, Trinity College Dublin, Ireland
Jennifer C. Hengeveld
Complex Trait Genomics Laboratory, Smurfit Institute of Genetics, Trinity College Dublin, Ireland
Alice Vajda
Complex Trait Genomics Laboratory, Smurfit Institute of Genetics, Trinity College Dublin, Ireland
Colette Donaghy
Department of Neurology, Western Health & Social Care Trust, Belfast, United Kingdom
Siobhan Hutchinson
Department of Neurology, St James's Hospital, Dublin, Ireland
Russel L. McLaughlin
Complex Trait Genomics Laboratory, Smurfit Institute of Genetics, Trinity College Dublin, Ireland
Orla Hardiman
Computational Neuroimaging Group, Biomedical Sciences Institute, Trinity College Dublin, Ireland
Peter Bede
Computational Neuroimaging Group, Biomedical Sciences Institute, Trinity College Dublin, Ireland; Corresponding author.
Primary lateral sclerosis (PLS) is an adult-onset upper motor neuron disease manifesting in progressive spasticity and gradually resulting in considerably motor disability. In the absence of early disease-specific diagnostic indicators, the majority of patients with PLS face a circuitous diagnostic journey. Until the recent publication of consensus diagnostic criteria, 4-year symptom duration was required to establish the diagnosis. The new diagnostic criteria introduced the category of ‘probable PLS’ for patients with a symptom duration of 2–4 years. “Evolving diagnostic criteria in primary lateral sclerosis: The clinical and radiological basis of ''probable PLS'' [1]. This dataset provides radiological metrics in a cohort of ‘probable PLS’ patients, ‘definite PLS’ patients and age-matched healthy controls. Region-of-interest radiological data include diffusivity metrics in the corticospinal tracts and corpus callosum as well as mean cortical thickness values in the pre- and para-central gyri in each hemisphere. Our data indicate considerable grey matter and relatively limited white matter involvement in ‘probable PLS’ which supports the rationale for this diagnostic category as a clinically useful entity. The introduction of this diagnostic category will likely facilitate the timely recruitment of PLS patients into research studies and pharmacological trials before widespread neurodegenerative change ensues.